ArticleFrontiers in oncology2021

First-in-Human Trial of EphA2-Redirected CAR T-Cells in Patients With Recurrent Glioblastoma: A Preliminary Report of Three Cases at the Starting Dose.

Qingtang Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.